Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 187
2
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

Investigating the epidemiology of elephant endotheliotropic herpesvirus in Myanmar

Elephant endotheliotropic herpesvirus hemorrhagic disease (EEHV-HD) is the leading cause of death of young Asian...

Circulating biomarkers of fibrosis in captive gorillas: a pilot study

Heart disease is the leading cause of death for gorillas in captivity. The ultimate goal of this project is...

Backer Badge Funded